Cryopep hemostasis coagulation - Protein C human deficient plasma (acquired)

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS ACQUIRED DEFICIENT PLASMAS (BOTTLES)

Protein C human deficient plasma (acquired)

Packaging in bottle. The minimum packaged volume is 50 mL. The price offer is based on the volume requested.

Reference	6-PPDPCA
Presentation	Vial
Format	Minimum 50 mL
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Quote	Product sheet
6-PPDPCA	Vial	Minimum 50 mL

Price list, safety data sheets and notices are accessible to our registered customers.

Protein C is a 62 kDa glycoprotein, synthesized by the liver in the presence of vitamin K. CP is at the center of a physiological system that inhibits coagulation: the anticoagulant system of protein C.
Thrombin associated with thrombomodulin loses its procoagulant properties at the same time as it activates PC to active protein C (PCa).
PCa in the presence of protein S, calcium and phospholipids is capable of cleaving FVa and FVIIIa blocking the amplification loop of thrombin generation.

Special plasmas are derived from patients with acquired deficiency, severe or moderate, or presenting a particular profile.
No buffer or preservatives are added.
Quickly frozen at -80° C, the plasma maintains perfectly intact the matrix.
All plasmas are stable when stored at -40° C to -80° C.
We carefully pack with dry ice during shipment.
No additive or preservative.
Expiry date > 1 year.
Plastic vials.

Minimize test time.
Ready to use.

APC Resistance Kit
C Diluent / S Diluent
CRYOcheck™ Clot C™
Human Protein C congenital deficient plasma
OLIGOBIND® APC Activity Assay
Plasma with high level of C protein: > 150 %
Protein C Immunodepleted Deficient Human Plasma
TECHNOCHROM® Protein C
TECHNOZYM® PCI Actibind® ELISA Kit

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS ACQUIRED DEFICIENT PLASMAS (BOTTLES)

Protein C human deficient plasma (acquired)

Price list, safety data sheets and notices are accessible to our registered customers.

Price list, safety data sheets and notices are accessible to our registered customers.

Cryopep Catalogue
Thrombosis Haemostasis 2024

Cryopep Catalogue
Haemostasis Research 2024

Cryopep DEFICIENT PLASMAS

Product sheet Protein C human deficient plasma (acquired)

CRYOPEP

You must identify yourself to search for a certificate of analysis

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS ACQUIRED DEFICIENT PLASMAS (BOTTLES)

Protein C human deficient plasma (acquired)

Product sheet

Price list, safety data sheets and notices are accessible to our registered customers.

Price list, safety data sheets and notices are accessible to our registered customers.

Cryopep CatalogueThrombosis Haemostasis 2024

Cryopep CatalogueHaemostasis Research 2024

Cryopep DEFICIENT PLASMAS

Product sheet Protein C human deficient plasma (acquired)

Cryopep Catalogue
Thrombosis Haemostasis 2024

Cryopep Catalogue
Haemostasis Research 2024